Learning Systems Lead - Limerick at Eli Lilly and Company

Limerick, County Limerick, Ireland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Systems thinking and technical expertise in learning technologies
Experience with data analytics for assessing training effectiveness and identifying competency gaps
Knowledge of regulatory, compliance, and scientific training needs in a highly regulated environment
Ability to integrate adult learning principles and modern instructional design
Capability to partner with site, global, scientific, manufacturing, and quality teams
Skills in project scoping and leveraging learning services suppliers

Responsibilities

Support the integration and optimization of learning technology platforms and systems
Assist in the digital transformation of learning and data-driven decision-making
Partner with site and global teams to implement innovative learning solutions
Support the design and maintenance of scalable, competency-based curricula and adaptive assignment frameworks
Utilize data analytics to assess training effectiveness and identify competency gaps
Collaborate with scientific, manufacturing, and quality teams to enhance training outcomes and compliance
Contribute to continuous improvement and future innovation in a highly regulated environment
Identify and analyze capability gaps using performance data and feedback
Collaborate with site leaders, Global MQ L&D Center of Excellence, and L&D Network to define and standardize role-based competency requirements
Develop and implement effective, site-related training solutions that meet business needs and regulatory standards
Localize global learning assets for the site
Integrate adult learning principles and modern instructional design into training programs
Create initial project scope documents, leveraging learning services suppliers for outsourced work
Ensure accurate training documentation and practices meet internal and external regulatory requirements
Conduct periodic reviews of training effectiveness and address compliance gaps proactively
Create, review, and oversee execution of implementation plans, coordinating with personnel on SOPs and other documents
Support the qualification and development of capabilities through on-the-job instructor and SME enablement

Skills

Learning Technologies

Data Analytics

Systems Integration

Regulatory Compliance

Competency-Based Curricula

Digital Learning Solutions

Training Effectiveness

LMS Optimization

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free